WallStSmart
ADIL

Adial Pharmaceuticals Inc

NASDAQ: ADIL · HEALTHCARE · BIOTECHNOLOGY

$1.55
-0.64% today

Updated 2026-04-29

Market cap
$2.21M
P/E ratio
P/S ratio
EPS (TTM)
$-11.93
Dividend yield
52W range
$2 – $30
Volume
0.1M

Adial Pharmaceuticals Inc (ADIL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-8.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-7553.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.2%
2026-03-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-11.48-439.0%$1.73$1.64-5.2%
2025-11-13$-0.08+79.5%$0.33$0.33-1.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-2.13$-11.48-439.0%
2025-09-30$-0.39$-0.08+79.5%
2025-06-30$-0.39$-0.18+53.8%
2025-03-31$-0.50$-0.34+31.3%
2024-12-31$-0.33$-0.15+54.5%$564.00
2024-09-30$-0.44$-0.38+13.6%
2024-06-30$-0.53$-0.59-11.3%
2024-03-31$-0.33$-0.62-87.9%$32246.00
2023-12-31$-0.76$-1.35-77.6%
2023-09-30$-1.13$-1.18-4.4%
2023-06-30$-1.50$0.96+164.0%
2023-03-31$-0.14$-0.11+21.4%

Frequently asked questions

Has Adial Pharmaceuticals Inc beaten earnings estimates?
Adial Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -8.8% over the last 4 quarters.
How does ADIL stock react to earnings?
ADIL stock has moved an average of -3.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.